$4550
$2730
The software as a medical device market is expected to reach USD 86,451.62 million by 2027 from US$ 18,488.00 Mn in 2019; it is estimated to grow at a CAGR of 21.9% during 2020–2027.
Software as a medical device is defined as a software solution used for one or more medical purposes without the software actually being a part of any medical hardware. These solutions can be used across a large range of technology platforms, including medical device, commercial "off-the-shelf" platforms, virtual networks, and others. The unique features of these devices that help them act more than a traditional medical device helps to promote innovation in digital healthcare and protect patient safety. The growth of the market is attributed to the increasing adoption of Internet of Things (IoT) and connected devices in healthcare sector, and advantages of software as a medical device, among others. However, the threat of data breach obstructs the growth of the market to a certain extent. Asia Pacific is expected to register highest CAGR in the market during the forecast period owing to rising healthcare infrastructure and increasing number of healthcare technology-based startups in the region.
Lucrative Regional Software as a Medical Device Markets
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Advantages of Software as a Medical Device
The number of technological innovations in the healthcare information technology has dramatically increased over the past few years. Wireless connectivity, artificial intelligence and cloud computing and artificial intelligence are some of the prominent advancements that have helped to transform healthcare. In addition, development of software solutions that now act as medical devices have been categorized and approved by FDA as well as European Commission are now likely to take over as leading edge technologies continuing to a source of seismic shift in healthcare modernization.
The mobile-based applications have seeped in and proved to be an important part of the healthcare for medical as well as non-medical purposes. These software solutions have become an inherent part of the patients’ life in few cases. The applications of SaMD are now not only limited to diagnosis and have widened to make their place in treatment as well as monitoring processes. These software have gained a significant attention as these are able to be run on non-medical computing platforms including personal smartphones, tablets and laptops whose use is now very common and penetrated deep in all the countries.
The SaMD has particularly witnessed a fast growth within the recent years, as there is no hardware involved and the applications have very few constraints for using fast feedback loops for improvement. These solutions are also being piloted constantly to better enable innovation and ensure patient safety as well improve clinical significance at the same time.
There are various advantages associated with the use of these solutions. For instance, software as medical device helps to amplify the effectiveness of medical devices and existing treatment plans thereby offering fast and high-quality data collection leading to better health outcomes. Furthermore, these solutions helps to enhance the builds on existing builds as these are faster and cheaper to update than the hardware solutions. The easy solicitation of user feedback on host devices also assists in shortening market time, quicker product iterations and faster innovations. Thus, the advantages offered by these solutions are expected to drive the market for software as a medical device market over the coming years.
Device Type-Based Market Insights
In 2019, the PCs/laptops segment accounted for the largest market share of the global software as a medical device market, by device type. The segment is expected to continue its dominance, in terms of market share, over the forecast period owing to consistent developments in the laptop designs, enabling the incorporation of smart sensors that is transforming the compatibility between these devices and the SaMD.. Further, the laptops and computers are now being evolved into complex hardware systems that can act as integrating tools as well as can conduct various monitoring and advanced healthcare diagnostics through new in-built features. On the other hand, the growing adoption of smartphones and the interest of software developers toward building smartphone-compatible healthcare apps acting as a medical device are expected to lead the smartphones/tablets segments toward the highest CAGR during the forecast period.
Software as a Medical Device Market, by Device Type – 2019 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Application-Based Market Insights
The software as medical device market, by application, is segmented into screening and diagnosis, monitoring and alerting, and disease management. The screening and diagnostics segment held the largest share of the market in 2019, whereas the monitoring and alerting segment is anticipated to register the highest CAGR during the forecast period.
Deployment-Based Market Insights
The software as medical device market, by deployment type, is segmented into cloud and on-premises. The cloud segment held a larger share of the market in 2019, and is anticipated to register a greater CAGR during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Software as a Medical Device Market: Strategic Insights
Market Size Value in US$ 18,488.00 Million in 2019 Market Size Value by US$ 86,451.62 Million by 2027 Growth rate CAGR of 21.9% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Software as a Medical Device Market: Strategic Insights
Market Size Value in | US$ 18,488.00 Million in 2019 |
Market Size Value by | US$ 86,451.62 Million by 2027 |
Growth rate | CAGR of 21.9% from 2020-2027 |
Forecast Period | 2020-2027 |
Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to AnalystPartnership is the most commonly adopted strategy by the software as medical devices market companies to expand their footprint worldwide and meet the growing demand. This strategy also helps them broaden their product portfolios. The players adopt the strategies of partnerships and collaborations to enlarge customer base across the world, which also permits them to maintain their brand name globally. For instance, in April 2020, CompliancePath and Ideagen entered into a product validation partnership to extend their ongoing validation accelerator program for the inclusion of all life science-related software products.
Global Software as a Medical Device Market – By Device Type
- PCs/Laptops
- Smartphone/Tablets
- Wearable Devices
Global Software as a Medical Device Market – By Application
- Screening and Diagnostics
- Monitoring and alerting
- Disease management
Global Software as a Medical Device Market – By Deployment Type
- Cloud
- On-Premise
Global Software as a Medical Device Market – By Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
- South America
- Brazil
- Argentina
- Rest of South America
Company Profiles
- Velentium LLC
- Tietronix Software, Inc.
- S3 Connected Health
- Zühlke Group
- Science Group
- Inzentiz
- Cambridge Consultants Inc
- BrightInsight, Inc.
- CompliancePath
- Jabil Inc.
- Phillips-Medisize
- Pro4People Sp. Z.o.o
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Device Type , Application , Deployment Type , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Software as a Medical Device Market – By Device Type
1.3.2 Global Software as a Medical Device Market – By Application
1.3.3 Global Software as a Medical Device Market – By Deployment Type
1.3.4 Global Software as a Medical Device Market – By Geography
2. Software as a Medical Device Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Software as a Medical Device – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America
4.2.2 Europe
4.2.3 Asia Pacific
4.2.4 Middle East & Africa
4.2.5 South and Central America
4.3 Expert Opinion
5. Global Software as a Medical Device Market – Industry Dynamics
5.1 Key Drivers
5.1.1 Increasing adoption of IoT in healthcare
5.1.2 Advantages of Software as a Medical Device (SaMD)
5.2 Key Market Restraints
5.2.1 Threat of Data Breach
5.3 Key Market Opportunities
5.3.1 Connected healthcare in emerging nations
5.4 Future Trends
5.4.1 Increasing number of wearable medical devices
5.5 Impact Analysis
6. Software as a Medical Device Market – Global Analysis
6.1 Global Software as a Medical Device Market Revenue Forecast And Analysis
6.2 Global Software as a Medical Device Market, By Geography - Forecast And Analysis
7. Software as a Medical Device Market Analysis – By Device Type
7.1 Overview
7.2 Software as a Medical Device Market Revenue Share, by Device Type (2019 and 2027)
7.3 PCs/Laptop
7.3.1 Overview
7.3.2 PCs/Laptop: Software as a Medical Device Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Smartphones/Tablets
7.4.1 Overview
7.4.2 Smartphones/Tablets: Software as a Medical Device Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Wearable Devices
7.5.1 Overview
7.5.2 Wearable Devices: Software as a Medical Device Market – Revenue and Forecast to 2027 (US$ Million)
8. Software as a Medical Device Market Analysis – By Application
8.1 Overview
8.2 Software as a Medical Device Market Revenue Share, by Application (2019 and 2027)
8.3 Screening and Diagnosis
8.3.1 Overview
8.3.2 Screening and Diagnosis: Software as a Medical Device Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Monitoring and Alerting
8.4.1 Overview
8.4.2 Monitoring and Alerting: Software as a Medical Device Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Disease Management
8.5.1 Overview
8.5.2 Disease Management: Software as a Medical Device Market – Revenue and Forecast to 2027 (US$ Million)
9. Software as a Medical Device Market Analysis – By Deployment Type
9.1 Overview
9.2 Software as a Medical Device Market Revenue Share, by Deployment Type (2019 and 2027)
9.3 Cloud
9.3.1 Overview
9.3.2 Cloud: Software as a Medical Device Market – Revenue and Forecast to 2027 (US$ Million)
9.4 On-Premise
9.4.1 Overview
9.4.2 On-Premise: Software as a Medical Device Market – Revenue and Forecast to 2027 (US$ Million)
10. Software as a Medical Device Market – Geographic Analysis
10.1.1 Overview
10.1.2 North America: Software as a Medical Device Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Software as a Medical Device Market, by Device Type, 2018–2027 (USD Million)
10.1.4 North America: Software as a Medical Device Market, by Application, 2018–2027 (USD Million)
10.1.5 North America: Software as a Medical Device Market, by Deployment Type, 2018–2027 (USD Million)
10.1.6 North America: Software as a Medical Device Market, by Country, 2019 & 2027 (%)
10.1.7 US: Software as a Medical Device Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Software as a Medical Device Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Software as a Medical Device Market, by Device Type, 2018–2027 (USD Million)
10.1.7.3 US: Software as a Medical Device Market, by Application, 2018–2027 (USD Million)
10.1.7.4 US: Software as a Medical Device Market, by Deployment Type, 2018–2027 (USD Million)
10.1.8 Canada: Software as a Medical Device Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Software as a Medical Device Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Software as a Medical Device Market, by Device Type, 2018–2027 (USD Million)
10.1.8.3 Canada: Software as a Medical Device Market, by Application, 2018–2027 (USD Million)
10.1.8.4 Canada: Software as a Medical Device Market, by Deployment Type, 2018–2027 (USD Million)
10.1.9 Mexico: Software as a Medical Device Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Software as a Medical Device Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: Software as a Medical Device Market, by Device Type, 2018–2027 (USD Million)
10.1.9.3 Mexico: Software as a Medical Device Market, by Application, 2018–2027 (USD Million)
10.1.9.4 Mexico: Software as a Medical Device Market, by Deployment Type, 2018–2027 (USD Million)
10.2 Europe: Software as s Medical Device (SaMD) Market
10.2.1 Overview
10.2.2 Europe: Software as s Medical Device (SaMD) Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe: Software as s Medical Device (SaMD) Market, by Device Type, 2018–2027 (USD Million)
10.2.4 Europe: Software as s Medical Device (SaMD) Market, by Application, 2018–2027 (USD Million)
10.2.5 Europe: Software as s Medical Device (SaMD) Market, by Deployment Type, 2018–2027 (USD Million)
10.2.6 Europe: Software as s Medical Device (SaMD) Market, by Country, 2018 & 2027 (%)
10.2.7 Germany: Software as s Medical Device (SaMD) Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.1 Germany: Software as s Medical Device (SaMD) Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.2 Germany: Software as s Medical Device (SaMD) Market Device Type, 2018–2027 (USD Million)
10.2.7.3 Germany: Software as s Medical Device (SaMD) Market, by Application, 2018–2027 (USD Million)
10.2.7.4 Germany: Software as s Medical Device (SaMD) Market, by Deployment Type, 2018–2027 (USD Million)
10.2.8 UK: Software as a Medical Device (SaMD) Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.1 UK: Software as a Medical Device (SaMD) Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.2 United Kingdom: Software as a Medical Device (SaMD) Market Device Type, 2018–2027 (USD Million)
10.2.8.3 United Kingdom: Software as s Medical Device (SaMD) Market, by Application, 2018–2027 (USD Million)
10.2.8.4 United Kingdom: Software as s Medical Device (SaMD) Market, by Deployment Type, 2018–2027 (USD Million)
10.2.9 France: Software as s Medical Device (SaMD) Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.1 France: Software as a Medical Device (SaMD) Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.2 France: Software as a Medical Device (SaMD) Market Device Type, 2018–2027 (USD Million)
10.2.9.3 France: Software as s Medical Device (SaMD) Market, by Application, 2018–2027 (USD Million)
10.2.9.4 France: Software as s Medical Device (SaMD) Market, by Deployment Type, 2018–2027 (USD Million)
10.2.10 Spain: Software as a Medical Device (SaMD) Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Spain: Software as a Medical Device (SaMD) Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Spain: Software as s Medical Device (SaMD) Market Device Type, 2018–2027 (USD Million)
10.2.10.3 Spain: Software as s Medical Device (SaMD) Market, by Application, 2018–2027 (USD Million)
10.2.10.4 Spain: Software as s Medical Device (SaMD) Market, by Deployment Type, 2018–2027 (USD Million)
10.2.11 Italy: Software as a Medical Device (SaMD) Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Italy: Software as a Medical Device (SaMD) Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Italy: Software as a Medical Device (SaMD) Market Device Type, 2018–2027 (USD Million)
10.2.11.3 Italy: Software as s Medical Device (SaMD) Market, by Application, 2018–2027 (USD Million)
10.2.11.4 Italy: Software as s Medical Device (SaMD) Market, by Deployment Type, 2018–2027 (USD Million)
10.3 Asia Pacific: Software As A Medical Device Market
10.3.1 Overview
10.3.2 Asia Pacific: Software As A Medical Device Market - Revenue and Forecast to 2027 (USD Million)
10.3.3 Asia Pacific: Software As A Medical Device Market, by Device Type, 2018–2027 (USD Million)
10.3.4 Asia Pacific: Software As A Medical Device Market, by Application, 2018–2027 (USD Million)
10.3.5 Asia Pacific: Software As A Medical Device Market, by Deployment Type, 2018–2027 (USD Million)
10.3.6 Asia Pacific: Software As A Medical Device Market, by Country, 2018 & 2027 (%)
10.3.7 China: Software As A Medical Device Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.1 China: Software As A Medical Device Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.2 China: Software As A Medical Device Market, by Device Type, 2018–2027 (USD Million)
10.3.7.3 China: Software As A Medical Device Market, by Application, 2018–2027 (USD Million)
10.3.7.4 China: Software As A Medical Device Market, by Deployment Type, 2018–2027 (USD Million)
10.3.8 Japan: Software As A Medical Device Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.1 Japan: Software As A Medical Device Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.2 Japan: Software As A Medical Device Market, by Device Type, 2018–2027 (USD Million)
10.3.8.3 Japan: Software As A Medical Device Market, by Application, 2018–2027 (USD Million)
10.3.8.4 Japan: Software As A Medical Device Market, by Deployment Type, 2018–2027 (USD Million)
10.3.9 India: Software As A Medical Device Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.1 India: Software As A Medical Device Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.2 India: Software As A Medical Device Market, by Device Type, 2018–2027 (USD Million)
10.3.9.3 India: Software As A Medical Device Market, by Application, 2018–2027 (USD Million)
10.3.9.4 India: Software As A Medical Device Market, by Deployment Type, 2018–2027 (USD Million)
10.3.10 South Korea: Software As A Medical Device Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.1 South Korea: Software As A Medical Device Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.2 South Korea: Software As A Medical Device Market, by Device Type, 2018–2027 (USD Million)
10.3.10.3 South Korea: Software As A Medical Device Market, by Application, 2018–2027 (USD Million)
10.3.10.4 South Korea: Software As A Medical Device Market, by Deployment Type, 2018–2027 (USD Million)
10.3.11 Australia: Software As A Medical Device (SaMD) Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.1 Australia: Software As A Medical Device Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.2 Australia: Software As A Medical Device Market, by Device Type, 2018–2027 (USD Million)
10.3.11.3 Australia: Software As A Medical Device Market, by Application, 2018–2027 (USD Million)
10.3.11.4 Australia: Software As A Medical Device Market, by Deployment Type, 2018–2027 (USD Million)
10.4 Middle East & Africa: Software As A Medical Device Market
10.4.1 Overview
10.4.2 Middle East & Africa: Software As A Medical Device Market - Revenue and Forecast to 2027 (US$ Million)
10.4.3 Middle East & Africa: Software As A Medical Device Market, by Device Type, 2018–2027 (USD Million)
10.4.4 Middle East & Africa: Software As A Medical Device Market, by Application, 2018–2027 (USD Million)
10.4.5 Middle East & Africa: Software As A Medical Device Market, by Deployment Type, 2018–2027 (USD Million)
10.4.6 Middle East & Africa: Software As A Medical Device Market, by Country, 2018 & 2027 (%)
10.4.7 Saudi Arabia: Software As A Medical Device Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.1 Saudi Arabia: Software As A Medical Device Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.2 Saudi Arabia: Software As A Medical Device Market, by Device Type, 2018–2027 (USD Million)
10.4.7.3 Saudi Arabia: Software As A Medical Device Market, by Application, 2018–2027 (USD Million)
10.4.7.4 Saudi Arabia: Software As A Medical Device Market, by Deployment Type, 2018–2027 (USD Million)
10.4.8 UAE: Software As A Medical Device Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.1 UAE: Software As A Medical Device Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.2 UAE: Software As A Medical Device Market, by Device Type, 2018–2027 (USD Million)
10.4.8.3 UAE: Software As A Medical Device Market, by Application, 2018–2027 (USD Million)
10.4.8.4 UAE: Software As A Medical Device Market, by Deployment Type, 2018–2027 (USD Million)
10.4.9 South Africa: Software As A Medical Device Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.1 South Africa: Software As A Medical Device Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.2 South Africa: Software As A Medical Device Market, by Device Type, 2018–2027 (USD Million)
10.4.9.3 South Africa: Software As A Medical Device Market, by Application, 2018–2027 (USD Million)
10.4.9.4 South Africa: Software As A Medical Device Market, by Deployment Type, 2018–2027 (USD Million)
10.5 South and Central America: Software as a Medical Device (SaMD) Market
10.5.1 Overview
10.5.2 South and Central America: Software as a Medical Device (SaMD) Market - Revenue and Forecast to 2027 (US$ Million)
10.5.3 South and Central America: Software as a Medical Device (SaMD) Market Device Type, 2018–2027 (USD Million)
10.5.4 South and Central America: Software as s Medical Device (SaMD) Market, by Application, 2018–2027 (USD Million)
10.5.5 South and Central America: Software as a Medical Device (SaMD) Market, by Deployment Type, 2018–2027 (USD Million)
10.5.6 South and Central America: Software as a Medical Device (SaMD) Market, by Country, 2019 & 2027 (%)
10.5.7 Brazil: Software as a Medical Device (SaMD) Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Brazil: Software as a Medical Device (SaMD) Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.2 Brazil: Software as a Medical Device (SaMD) Market Device Type, 2018–2027 (USD Million)
10.5.7.3 Brazil: Software as s Medical Device (SaMD) Market, by Application, 2018–2027 (USD Million)
10.5.7.4 Brazil: Software as s Medical Device (SaMD) Market, by Deployment Type, 2018–2027 (USD Million)
10.5.8 Argentina: Software as a Medical Device (SaMD) Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.1 Argentina: Software as a Medical Device (SaMD) Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.2 Argentina: Software as s Medical Device (SaMD) Market Device Type, 2018–2027 (USD Million)
10.5.8.3 Argentina: Software as s Medical Device (SaMD) Market, by Application, 2018–2027 (USD Million)
10.5.8.4 Argentina: Software as s Medical Device (SaMD) Market, by Deployment Type, 2018–2027 (USD Million)
11. Impact Of COVID-19 Pandemic on Global Software As Medical Device Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment Of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
12. Software As Medical Device Market –Industry Landscape
12.1 Overview
12.2 Inorganic Growth Strategies
12.2.1 Overview
13. Company Profiles
13.1 Velentium LLC
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Tietronix Software Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 S3 Connected Health
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Zühlke Group
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Science Group
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Inzentiz
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Cambridge Consultants Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 BrightInsight, Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 CompliancePath
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Jabil Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Phillips-Medisize
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Pro4People Sp. z o.o.
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Software as a Medical Device Market, by Device Type – Revenue and Forecast to 2027 (USD Million)
Table 2. North America Software as a Medical Device Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 3. North America Software as a Medical Device Market, by Deployment Type – Revenue and Forecast to 2027 (USD Million)
Table 4. US Software as a Medical Device Market, by Device Type – Revenue and Forecast to 2027 (USD Million)
Table 5. US Software as a Medical Device Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 6. US Software as a Medical Device Market, by Deployment Type – Revenue and Forecast to 2027 (USD Million)
Table 7. Canada Software as a Medical Device Market, by Device Type – Revenue and Forecast to 2027 (USD Million)
Table 8. Canada Software as a Medical Device Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Software as a Medical Device Market, by Deployment Type – Revenue and Forecast to 2027 (USD Million)
Table 10. Mexico Software as a Medical Device Market, by Device Type – Revenue and Forecast to 2027 (USD Million)
Table 11. Mexico Software as a Medical Device Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 12. Mexico Software as a Medical Device Market, by Deployment Type – Revenue and Forecast to 2027 (USD Million)
Table 13. Table 1
Table 14. Table: 2
Table 15. Europe Software as s Medical Device (SaMD Market, by Device Type – Revenue and Forecast to 2027 (USD Million)
Table 16. Europe Software as s Medical Device (SaMD) Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 17. Europe Software as s Medical Device (SaMD) Market, by Sample Type – Revenue and Forecast to 2027 (USD Million)
Table 18. Germany Software as s Medical Device (SaMD) Market Device Type – Revenue and Forecast to 2027 (USD Million)
Table 19. Germany Software as s Medical Device (SaMD) Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 20. Germany Software as s Medical Device (SaMD) Market, by Deployment Type – Revenue and Forecast to 2027 (USD Million)
Table 21. Germany Software as s Medical Device (SaMD) Market, by Device Type– Revenue and Forecast to 2027 (USD Million)
Table 22. UK Software as s Medical Device (SaMD) Market Device Type – Revenue and Forecast to 2027 (USD Million)
Table 23. UK Software as s Medical Device (SaMD) Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 24. UK Software as s Medical Device (SaMD) Market, by Deployment Type – Revenue and Forecast to 2027 (USD Million)
Table 25. France Software as s Medical Device (SaMD) Market Device Type – Revenue and Forecast to 2027 (USD Million)
Table 26. France Software as s Medical Device (SaMD) Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 27. France Software as s Medical Device (SaMD) Market, by Deployment Type – Revenue and Forecast to 2027 (USD Million)
Table 28. Spain Software as s Medical Device (SaMD) Market Device Type – Revenue and Forecast to 2027 (USD Million)
Table 29. Spain Software as s Medical Device (SaMD) Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 30. Spain Software as s Medical Device (SaMD) Market, by Deployment Type – Revenue and Forecast to 2027 (USD Million)
Table 31. Italy Software as s Medical Device (SaMD) Market Device Type – Revenue and Forecast to 2027 (USD Million)
Table 32. Italy Software as s Medical Device (SaMD) Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 33. Italy Software as s Medical Device (SaMD) Market, by Deployment Type – Revenue and Forecast to 2027 (USD Million)
Table 34. Asia Pacific Software as a Medical Device Market, by Device Type – Revenue and Forecast to 2027 (USD Million)
Table 35. Asia Pacific Software as a Medical Device Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 36. Asia Pacific Software as a Medical Device Market, by Deployment Type – Revenue and Forecast to 2027 (USD Million)
Table 37. China Software As A Medical Device Market, by Device Type – Revenue and Forecast to 2027 (USD Million)
Table 38. China Software as a Medical Device Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 39. China Software as a Medical Device Market, by Deployment Type – Revenue and Forecast to 2027 (USD Million)
Table 40. Japan Software as a Medical Device Market, by Device Type – Revenue and Forecast to 2027 (USD Million)
Table 41. Japan Software as a Medical Device Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 42. Japan Software as a Medical Device Market, by Deployment Type – Revenue and Forecast to 2027 (USD Million)
Table 43. India Software as a Medical Device Market, by Device Type – Revenue and Forecast to 2027 (USD Million)
Table 44. India Software as a Medical Device Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 45. India Software as a Medical Device Market, by Deployment Type – Revenue and Forecast to 2027 (USD Million)
Table 46. South Korea Software as a Medical Device Market, by Device Type – Revenue and Forecast to 2027 (USD Million)
Table 47. South Korea Software as a Medical Device Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 48. South Korea Software as a Medical Device Market, by Deployment Type – Revenue and Forecast to 2027 (USD Million)
Table 49. Australia Software as a Medical Device Market, by Device Type – Revenue and Forecast to 2027 (USD Million)
Table 50. Australia Software as a Medical Device Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 51. Australia Software as a Medical Device Market, by Deployment Type – Revenue and Forecast to 2027 (USD Million)
Table 52. Middle East and Africa Software as a Medical Device Market, by Device Type – Revenue and Forecast to 2027 (USD Million)
Table 53. Middle East and Africa Software as a Medical Device Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 54. Middle East and Africa Software as a Medical Device Market, by Deployment Type – Revenue and Forecast to 2027 (USD Million)
Table 55. Saudi Arabia Software as a Medical Device Market, by Device Type – Revenue and Forecast to 2027 (USD Million)
Table 56. Saudi Arabia Software as a Medical Device Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 57. Saudi Arabia Software as a Medical Device Market, by Deployment Type – Revenue and Forecast to 2027 (USD Million)
Table 58. UAE Software as a Medical Device Market, by Device Type – Revenue and Forecast to 2027 (USD Million)
Table 59. UAE Software as a Medical Device Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 60. UAE Software as a Medical Device Market, by Deployment Type – Revenue and Forecast to 2027 (USD Million)
Table 61. Saudi Arabia Software as a Medical Device Market, by Device Type – Revenue and Forecast to 2027 (USD Million)
Table 62. Saudi Arabia Software as a Medical Device Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 63. Saudi Arabia Software as a Medical Device Market, by Deployment Type – Revenue and Forecast to 2027 (USD Million)
Table 64. South and Central America Software as a Medical Device (SaMD) Market Device Type – Revenue and Forecast to 2027 (USD Million)
Table 65. South and Central America Software as s Medical Device (SaMD) Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 66. South and Central America Software as s Medical Device (SaMD) Market, by Deployment Type – Revenue and Forecast to 2027 (USD Million)
Table 67. Brazil Software as s Medical Device (SaMD) Market Device Type – Revenue and Forecast to 2027 (USD Million)
Table 68. Brazil Software as s Medical Device (SaMD) Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 69. Brazil Software as s Medical Device (SaMD) Market, by Deployment Type – Revenue and Forecast to 2027 (USD Million)
Table 70. Argentina Software as s Medical Device (SaMD) Market Device Type – Revenue and Forecast to 2027 (USD Million)
Table 71. Argentina Software as s Medical Device (SaMD) Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 72. Argentina Software as s Medical Device (SaMD) Market, by Deployment Type – Revenue and Forecast to 2027 (USD Million)
Table 73. Recent Inorganic Growth Strategies In The Software As Medical Device Market
Table 74. Glossary of Terms, Skin aesthetic devices market
LIST OF FIGURES
Figure 1. Software as a Medical Device Market Segmentation
Figure 2. Software as a Medical Device Segmentation, By Region
Figure 3. Global Software as a Medical Device Market Overview
Figure 4. The PCs/Laptops Segment Held Largest Share of Device Type Segment In Software as a Medical Device Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Software as a Medical Device Market, By Geography (US$ Million)
Figure 7. Global Software as a Medical Device Market- Leading Country Markets (US$ Million)
Figure 8. North America PEST Analysis
Figure 9. Europe: PEST Analysis
Figure 10. Asia Pacific PEST Analysis
Figure 11. Middle East & Africa PEST Analysis
Figure 12. South and Central America PEST Analysis
Figure 13. Global Software as a Medical Device Market – Revenue Forecast And Analysis – 2019- 2027
Figure 14. Global Software as a Medical Device Market – By Geography Forecast And Analysis – 2019- 2027
Figure 15. Software as a Medical Device Market Revenue Share, by Device Type (2019 and 2027)
Figure 16. PCs/Laptop: Software as a Medical Device Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Smartphones/Tablets: Software as a Medical Device Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Wearable Devices: Software as a Medical Device Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Software as a Medical Device Market Revenue Share, by Application (2019 and 2027)
Figure 20. Screening and Diagnosis: Software as a Medical Device Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Monitoring and Alerting: Software as a Medical Device Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Disease Management: Software as a Medical Device Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Software as a Medical Device Market Revenue Share, by Deployment Type (2019 and 2027)
Figure 24. Cloud: Software as a Medical Device Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. On-Premise: Software as a Medical Device Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. North America: Software as a Medical Device Market, by Key Country – Revenue (2019) (USD Million)
Figure 27. North America Software as a Medical Device Market Revenue and Forecast to 2027 (USD Million)
Figure 28. North America: Software as a Medical Device Market, by Country, 2019 & 2027 (%)
Figure 29. US: Software as a Medical Device Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Canada: Software as a Medical Device Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Mexico: Software as a Medical Device Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. Europe: Software as s Medical Device (SaMD) Market, by Key Country – Revenue (2019) (USD Million)
Figure 33. Europe Software as s Medical Device (SaMD) Market Revenue and Forecast to 2027 (USD Million)
Figure 34. Europe: Software as s Medical Device (SaMD) Market, by Country, 2018 & 2027 (%)
Figure 35. Germany: Software as s Medical Device (SaMD) Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. UK: Software as a Medical Device (SaMD) Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. France: Software as a Medical Device (SaMD) Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. Spain: Software as a Medical Device (SaMD) Market – Revenue and Forecast to 2027 (USD Million)
Figure 39. Italy: Software as a Medical Device (SaMD) Market – Revenue and Forecast to 2027 (USD Million)
Figure 40. Asia Pacific: Software As A Medical Device Market, by Key Country – Revenue (2019) (USD Million)
Figure 41. Asia Pacific Software As A Medical Device Market Revenue and Forecast to 2027 (USD Million)
Figure 42. China: Software As A Medical Device Market – Revenue and Forecast to 2027 (USD Million)
Figure 43. Japan: Software As A Medical Device Market – Revenue and Forecast to 2027 (USD Million)
Figure 44. India: Software As A Medical Device Market – Revenue and Forecast to 2027 (USD Million)
Figure 45. South Korea: Software As A Medical Device Market – Revenue and Forecast to 2027 (USD Million)
Figure 46. Australia: Software As A Medical Device Market – Revenue and Forecast to 2027 (USD Million)
Figure 47. Middle East & Africa: Software As A Medical Device Market, by Key Country – Revenue (2019) (USD Million)
Figure 48. Middle East & Africa Software As A Medical Device Market Revenue and Forecast to 2027 (USD Million)
Figure 49. Middle East & Africa: Software As A Medical Device Market, by Country, 2018 & 2027 (%)
Figure 50. Saudi Arabia: Software As A Medical Device Market – Revenue and Forecast to 2027 (USD Million)
Figure 51. UAE: Software As A Medical Device Market – Revenue and Forecast to 2027 (USD Million)
Figure 52. South Africa: Software As A Medical Device Market – Revenue and Forecast to 2027 (USD Million)
Figure 53. South and Central America: Software as a Medical Device (SaMD) Market, by Key Country – Revenue (2019) (USD Million)
Figure 54. South and Central America Software as a Medical Device (SaMD) Market Revenue and Forecast to 2027 (USD Million)
Figure 55. South and Central America: Software as a Medical Device (SaMD) Market, by Country, 2019 & 2027 (%)
Figure 56. Brazil: Software as a Medical Device (SaMD) Market – Revenue and Forecast to 2027 (USD Million)
Figure 57. Argentina: Software as a Medical Device (SaMD) Market – Revenue and Forecast to 2027 (USD Million)
Figure 58. Impact of COVID-19 Pandemic in North American Country Markets
Figure 59. Impact of COVID-19 Pandemic in European Country Markets
Figure 60. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 61. Impact Of COVID-19 Pandemic In Rest of the World Countries Market
The List of Companies - SaMD Market
- Velentium LLC
- Tietronix Software, Inc.
- S3 Connected Health
- Zühlke Group
- Science Group
- Inzentiz
- Cambridge Consultants Inc
- BrightInsight, Inc.
- CompliancePath
- Jabil Inc.
- Phillips-Medisize
- Pro4People Sp. Z.o.o
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Software as a Medical Device Market
Apr 2020
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Apr 2020
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Apr 2020
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2020
Coagulation Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease Indications (Vitamin K Deficiency, Liver Disease, Disseminated Intravascular Coagulation & Pulmonary Embolism, Development of Circulating Anticoagulants, Hemophilia, Von Willebrand's Disease, and Others), Type [Clinical Laboratory Analyzers (Controls & Calibrators, Assays & Reagents, Instruments/Systems, Coagulation Factors, and Others) and Point-of-Care Testing Analyzers], Offering [Diagnosis (Prothrombin Time Testing, Fibrinogen Testing, Activated Clotting Time Testing, Activated Partial Thromboplastin Time Testing, D-Dimmer Testing, Platelets Function Testing, and Others) and Treatment (Anti-Fibrinolytic Drugs, Birth Control Pills, Desmopressin & Immunosuppressive Medicines, Vitamin K Supplements, Blood Thinners, Thrombin Inhibitors or Thrombolytics, Replacement Therapy, Catheter-Assisted Thrombus Removal, and Others)], Technology (Optical Technology, Mechanical Technology, Electrochemical Technology, and Others), End User (Clinical Laboratories, Hospitals, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)